Only in April and only at Maleva 31! The Nobivac KC vaccine is a nasal vaccine against bordetellosis and parainfluenza for dogs, known as "kennel cough," available at a special price — 25 euros instead of 40!
Vaccination is particularly relevant for dogs with a show career, dogs that often walk in dog walking areas (city parks, dog playgrounds), and also dogs that you plan to leave in care during vacation.
Limited availability! You can register by phone: 3377463, Maleva 31. By appointment only.
Why is the Nobivac KC vaccine needed?
The Nobivac KC vaccine provides dogs with protection against the two main agents of "kennel cough" — Bordetella bronchiseptica and the parainfluenza virus. This disease is characterized by severe coughing, which can lead to serious complications, especially in young or weakened animals.
The history and development of the vaccine
The Nobivac KC vaccine was developed after years of research aimed at creating a safe and effective means of preventing "kennel cough." This drug was thoroughly tested and received approval from leading veterinary associations around the world thanks to its high efficiency and minimal side effects.
The benefits of vaccination
Vaccination with the Nobivac KC not only effectively reduces the risk of developing bordetellosis and parainfluenza but also contributes to the formation of durable immunity, reducing the likelihood of infection and transmission of the infection to other dogs. In addition, the vaccine contributes to the strengthening of the overall health of animals, reducing the risk of developing other respiratory diseases.
How is vaccination carried out?
Vaccination is administered nasally, which ensures the rapid formation of local immunity in the respiratory tract of the dog, where the primary infection with the agents of "kennel cough" occurs. The procedure is quick, minimally stressful for the animal, and does not require a long recovery period.
Research results and reviews
According to the results of conducted studies, the Nobivac KC vaccine demonstrates high effectiveness. The experiments involved dogs of various age groups who were vaccinated. Observations showed that the symptoms of "kennel cough" were significantly mitigated or completely absent in vaccinated animals compared to the control group. Reviews from dog owners who have had their pets vaccinated confirm the high efficacy and safety of the drug, noting an improvement in the overall health condition of their pets.